Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Contingent Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Contingent Liabilities ₹55 Cr₹83 Cr₹35 Cr₹242 Cr₹361 Cr

What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?

The latest Contingent Liabilities ratio of MANKIND PHARMA is ₹55 Cr based on Mar2023 Consolidated results.
Year Contingent Liabilities
Mar2023₹55 Cr
Mar2022₹83 Cr
Mar2021₹35 Cr
Mar2020₹242 Cr
Mar2019₹361 Cr

How is Contingent Liabilities of MANKIND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2023 ₹55 Cr
-33.99
Mar2022 ₹83 Cr
137.32
Mar2021 ₹35 Cr
-85.60
Mar2020 ₹242 Cr
-33.06
Mar2019 ₹361 Cr -

Compare Contingent Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹84,588.7 Cr -6.1% -11.9% 54.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,290.0 Cr -0.9% 0.9% 62.6% Stock Analytics
CIPLA ₹113,357.0 Cr 3.5% 4.2% 51.8% Stock Analytics
ZYDUS LIFESCIENCES ₹111,134.0 Cr 12.2% 18% 103.8% Stock Analytics
DIVIS LABORATORIES ₹104,235.0 Cr 0.8% 5.6% 19.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,001.5 Cr -1% -2.4% 28.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-6.1%

-11.9%

54.1%

SENSEX

1.7%

1.5%

18.7%


You may also like the below Video Courses